Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Stock-based Employee Compensation

v3.22.2.2
Note 8 - Stock-based Employee Compensation
9 Months Ended
Sep. 25, 2022
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(8) Stock-Based Employee Compensation

 

On May 15, 2018, the Company’s stockholders approved a new 2018 Omnibus Incentive Plan (the "2018 Plan") which replaced the Amended and Restated 2005 Equity Incentive Plan (the "2005 Plan"), which expired on May 30, 2018. The 2018 Plan authorizes 2.5 million shares reserved for future grants. Awards that were previously awarded under the 2005 Plan that are forfeited or cancelled in the future are made available for grant or issuance under the 2018 Plan. The 1,649,394 shares that were authorized but unissued under the 2005 Plan as of May 15, 2018 were cancelled. As of September 25, 2022, there were no shares of common stock issuable upon exercise of currently outstanding options, and 33,420 currently outstanding unvested restricted stock awards under the 2005 Plan. As of September 25, 2022, there were 945,960 currently outstanding unvested restricted stock awards, restricted stock units, and performance stock awards under the 2018 Plan. As of September 25, 2022, the 2018 Plan has 1,647,123 shares available for future grants. During the first thirty-nine weeks of fiscal year 2022, the Company issued 268,988 restricted stock awards and units and 174,661 performance-based stock units to directors, officers and other employees of the Company. Of the 443,649 restricted stock units, restricted stock units and performance stock awards issued during the first thirty-nine weeks of fiscal year 2022, 98,769 shares will vest in fiscal year 2023, 98,769 shares will vest in fiscal year 2024, 238,891 shares will vest in fiscal year 2025 and 7,220 shares will vest in fiscal year 2027. Of the 238,891 shares that will vest in fiscal year 2025, 174,661 shares are variable, based on performance targets, and are reflected assuming they will be earned at 100% of target.  Total stock compensation expense recognized during the first thirty-nine weeks of fiscal years 2022 and 2021 was $5.9 million and $3.8 million, respectively.